| __timestamp | Alkermes plc | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 199905000 | 6795238 |
| Thursday, January 1, 2015 | 311558000 | 7454247 |
| Friday, January 1, 2016 | 374130000 | 10345862 |
| Sunday, January 1, 2017 | 421578000 | 16984203 |
| Monday, January 1, 2018 | 526408000 | 16187290 |
| Tuesday, January 1, 2019 | 599449000 | 9299233.54 |
| Wednesday, January 1, 2020 | 538827000 | 19232000 |
| Friday, January 1, 2021 | 560977000 | 23611000 |
| Saturday, January 1, 2022 | 605747000 | 26700000 |
| Sunday, January 1, 2023 | 689751000 | 28215000 |
| Monday, January 1, 2024 | 645238000 |
Infusing magic into the data realm
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Summit Therapeutics Inc. and Alkermes plc from 2014 to 2023. Over this period, Alkermes plc consistently outspent Summit Therapeutics, with its SG&A expenses peaking at nearly 690 million in 2023, a staggering 24% increase from 2014. In contrast, Summit Therapeutics saw a more modest rise, with expenses growing by approximately 315% over the same period, reaching 28 million in 2023. This disparity highlights Alkermes' aggressive investment in administrative and sales functions, potentially driving its market presence. Meanwhile, Summit's leaner approach may reflect a strategic focus on cost efficiency. These insights offer a window into the differing operational strategies of these two pharmaceutical giants.
Operational Costs Compared: SG&A Analysis of Sanofi and Alkermes plc
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? Summit Therapeutics Inc. or Catalyst Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and Vericel Corporation
Summit Therapeutics Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Evotec SE
Selling, General, and Administrative Costs: Walgreens Boots Alliance, Inc. vs Alkermes plc
Comparing SG&A Expenses: Alkermes plc vs Alpine Immune Sciences, Inc. Trends and Insights
Alkermes plc or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
Alkermes plc vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Alkermes plc vs MiMedx Group, Inc. Trends and Insights